Publication | Open Access
CLINICAL BENEFITS OF TRAMIPROSATE IN ALZHEIMER’S DISEASE ARE ASSOCIATED WITH HIGHER NUMBER OF APOE4 ALLELES: THE “APOE4 GENE-DOSE EFFECT”
63
Citations
0
References
2016
Year
Neurodegenerative DiseasesAlzheimer's DiseaseMedicineDegenerative PathologyNeurologyNeuroscienceNeurodegenerationAging-associated DiseasePharmacology
No additional data available for this publication yet. Check back later!